Fny Investment Advisers, LLC Bridge Bio Pharma, Inc. Transaction History
Fny Investment Advisers, LLC
- $208 Million
- Q3 2024
A detailed history of Fny Investment Advisers, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 8,650 shares of BBIO stock, worth $202,583. This represents 0.11% of its overall portfolio holdings.
Number of Shares
8,650
Previous 5,750
50.43%
Holding current value
$202,583
Previous $145,000
51.72%
% of portfolio
0.11%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$592 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$588 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$333 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$292 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$142 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.47B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...